Kenneth Rabin

1

Article

0

Comments
The increasingly well-coordinated global anti-vaccine movement has repurposed itself to challenge the very reality of COVID-19. Hasan Esen/Anadolu Agency via Getty Images

COVID‑19: A global survey shows worrying signs of vaccine hesitancy

Scott C. Ratzan, CUNY Graduate Center; Agnes Binagwaho, University of Global Health Equity; Heidi Larson, London School of Hygiene & Tropical Medicine; Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); Kenneth Rabin, CUNY Graduate Center, and Lawrence O. Gostin, Georgetown University

A safe, effective COVID-19 vaccine is expected to be developed in record time and may be approved for production, distribution and acceptance some time in 2021.

Contact Kenneth for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision